lansoprazole has been researched along with Hypertrophy, Left Ventricular in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we investigated the effects of lansoprazole on cardiac hypertrophy and heart failure, as well as the underlying mechanisms." | 7.96 | Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin. ( Bin, J; Chen, L; Chen, Z; Kitakaze, M; Li, Y; Liao, W; Liao, Y; Lin, H; Wang, Q; Wang, Y; Zheng, C; Zhu, H; Zhu, Y, 2020) |
| " Here, we investigated the effects of lansoprazole on cardiac hypertrophy and heart failure, as well as the underlying mechanisms." | 3.96 | Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin. ( Bin, J; Chen, L; Chen, Z; Kitakaze, M; Li, Y; Liao, W; Liao, Y; Lin, H; Wang, Q; Wang, Y; Zheng, C; Zhu, H; Zhu, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, H | 1 |
| Li, Y | 1 |
| Zhu, H | 1 |
| Wang, Q | 1 |
| Chen, Z | 1 |
| Chen, L | 1 |
| Zhu, Y | 1 |
| Zheng, C | 1 |
| Wang, Y | 1 |
| Liao, W | 1 |
| Bin, J | 1 |
| Kitakaze, M | 1 |
| Liao, Y | 1 |
1 other study available for lansoprazole and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
Topics: Animals; Aorta; beta Catenin; Cell Proliferation; Cells, Cultured; Constriction; Disease Models, Ani | 2020 |